These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1288510)

  • 41. Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder.
    Haupt M; Thommes M; Heidenreich A; Breitkreutz J
    J Control Release; 2013 Sep; 170(2):161-6. PubMed ID: 23732944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of different curcumin dosages on human gall bladder.
    Rasyid A; Rahman AR; Jaalam K; Lelo A
    Asia Pac J Clin Nutr; 2002; 11(4):314-8. PubMed ID: 12495265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome.
    Sand PK; Johnson Ii TM; Rovner ES; Ellsworth PI; Oefelein MG; Staskin DR
    BJU Int; 2011 Feb; 107(4):612-20. PubMed ID: 20707790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose-response effects of oral loxiglumide on postprandial gall-bladder emptying in man.
    Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Bekkering M; Giacovelli G; D'Amato M; Rovati LC
    Arzneimittelforschung; 1992 Nov; 42(11):1359-62. PubMed ID: 1492852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of tiemonium iodide on colonic motility in dogs].
    Okada K; Imai H; Togawa Y; Nagaoka S; Nozaki M; Tsurumi K; Fujimura H
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):495-503. PubMed ID: 6962171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gall bladder contractility in preterm infants.
    Lehtonen L; Svedström E; Kero P; Korvenranta H
    Arch Dis Child; 1993 Jan; 68(1 Spec No):43-5. PubMed ID: 8439199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.
    Staskin DR; Cardozo L
    Int J Clin Pract; 2009 Jun; 63(6):973-6. PubMed ID: 19459997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of combined use of trospium chloride and melatonin on in vitro contractility of rat urinary bladder.
    Onur R; Ozcan M; Tuygun U; Ozan T; Ayar A; Orhan I
    Urology; 2010 Apr; 75(4):873-7. PubMed ID: 20022086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors that affect the variability in heart rate during endoscopic retrograde cholangiopancreatography.
    Christensen M; Reinert R; Rasmussen V; Schulze S; Rosenberg J
    Eur J Surg; 2002; 168(10):546-51. PubMed ID: 12666694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.
    Staskin D; Kay G; Tannenbaum C; Goldman HB; Bhashi K; Ling J; Oefelein MG
    Int J Clin Pract; 2010 Aug; 64(9):1294-300. PubMed ID: 20561092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics.
    Bexten M; Oswald S; Grube M; Jia J; Graf T; Zimmermann U; Rodewald K; Zolk O; Schwantes U; Siegmund W; Keiser M
    Mol Pharm; 2015 Jan; 12(1):171-8. PubMed ID: 25466967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release.
    Chancellor MB; Oefelein MG; Vasavada S
    Neurourol Urodyn; 2010 Apr; 29(4):551-4. PubMed ID: 19634167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacological studies on antispasmodics. IV. Ganglion blocking activity of 3-(di-2-thienylmethylene)-5-methyl-trans-quinolizidinium bromide (HSR-902) and the correlation between its blocking activity and its inhibitory activity towards urinary bladder contraction (author's transl)].
    Kubo S; Morikawa K; Yamazaki M; Matsubara I; Kato H
    Nihon Yakurigaku Zasshi; 1981 Nov; 78(5):483-90. PubMed ID: 6120131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study.
    Dmochowski RR; Sand PK; Zinner NR; Staskin DR
    Urology; 2008 Mar; 71(3):449-54. PubMed ID: 18342185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The problem of the impairment of the action of parasympatholytic substances. Ophthalmologic criteria and methods].
    Mehlfeld G; Bleichert A
    Arzneimittelforschung; 1986 Feb; 36(2):271-3. PubMed ID: 3964335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of p-glycoprotein in limiting brain penetration of the peripherally acting anticholinergic overactive bladder drug trospium chloride.
    Geyer J; Gavrilova O; Petzinger E
    Drug Metab Dispos; 2009 Jul; 37(7):1371-4. PubMed ID: 19389858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Trospium chloride in the treatment of idiopathic and neurogenic detrusor overactivity].
    Mazo EB; Krivoborodov GG; Shkol'nikov ME; Babanina GA; Kozyrev SV; Korshunov ES
    Urologiia; 2005; (4):56-9. PubMed ID: 16158750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time to onset of improvement in symptoms of overactive bladder using antimuscarinic treatment.
    Rudy D; Cline K; Harris R; Goldberg K; Dmochowski R
    BJU Int; 2006 Mar; 97(3):540-6. PubMed ID: 16469022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of N-butylscopolamine on sphincter of Oddi motility in patients during routine ERCP--a manometric study.
    Allescher HD; Neuhaus H; Hagenmüller F; Classen M
    Endoscopy; 1990 Jul; 22(4):160-3. PubMed ID: 2209497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacological studies on antispasmodics. V. Effect of 3-(di-2-thienylmethylene)-5-methyl-trans-quinolizidinium bromide (HSR-902) on the junctional transmission of pelvic nerve ending in isolated urinary bladder (author's transl)].
    Kubo S; Morikawa K; Yamazaki M; Matsubara I; Kato H
    Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):571-7. PubMed ID: 6277751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.